Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD

24.46  -0.1 (-0.41%)

After market: 24.75 +0.29 (+1.19%)

Fundamental Rating

3

Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 191 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of QDEL have multiple concerns. QDEL is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year QDEL was profitable.
QDEL had a positive operating cash flow in the past year.
In multiple years QDEL reported negative net income over the last 5 years.
Each year in the past 5 years QDEL had a positive operating cash flow.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of -31.94%, QDEL is in line with its industry, outperforming 42.93% of the companies in the same industry.
QDEL's Return On Equity of -68.76% is in line compared to the rest of the industry. QDEL outperforms 42.41% of its industry peers.
The Return On Invested Capital of QDEL (0.67%) is better than 67.54% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for QDEL is below the industry average of 7.68%.
Industry RankSector Rank
ROA -31.94%
ROE -68.76%
ROIC 0.67%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

The Operating Margin of QDEL (1.65%) is better than 67.54% of its industry peers.
In the last couple of years the Operating Margin of QDEL has declined.
Looking at the Gross Margin, with a value of 46.23%, QDEL is doing worse than 61.26% of the companies in the same industry.
QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 46.23%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

QDEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, QDEL has more shares outstanding
QDEL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for QDEL is higher compared to a year ago.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

QDEL has an Altman-Z score of 0.82. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of QDEL (0.82) is comparable to the rest of the industry.
QDEL has a Debt/Equity ratio of 0.72. This is a neutral value indicating QDEL is somewhat dependend on debt financing.
QDEL's Debt to Equity ratio of 0.72 is on the low side compared to the rest of the industry. QDEL is outperformed by 68.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACC0.07
WACC9.35%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.22 indicates that QDEL should not have too much problems paying its short term obligations.
The Current ratio of QDEL (1.22) is worse than 81.15% of its industry peers.
QDEL has a Quick Ratio of 1.22. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.69, QDEL is not doing good in the industry: 86.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.69
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

The earnings per share for QDEL have decreased strongly by -55.21% in the last year.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
QDEL shows a decrease in Revenue. In the last year, the revenue decreased by -7.17%.
Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-55.21%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-46.15%
Revenue 1Y (TTM)-7.17%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-4.69%

3.2 Future

Based on estimates for the next years, QDEL will show a very strong growth in Earnings Per Share. The EPS will grow by 28.34% on average per year.
QDEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.57% yearly.
EPS Next Y29.93%
EPS Next 2Y34.34%
EPS Next 3Y33.27%
EPS Next 5Y28.34%
Revenue Next Year-2.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.2%
Revenue Next 5Y2.57%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.22, which indicates a correct valuation of QDEL.
QDEL's Price/Earnings ratio is rather cheap when compared to the industry. QDEL is cheaper than 89.01% of the companies in the same industry.
QDEL is valuated cheaply when we compare the Price/Earnings ratio to 28.33, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.18 indicates a reasonable valuation of QDEL.
QDEL's Price/Forward Earnings ratio is rather cheap when compared to the industry. QDEL is cheaper than 94.76% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.37, QDEL is valued rather cheaply.
Industry RankSector Rank
PE 13.22
Fwd PE 10.18
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

QDEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QDEL is cheaper than 93.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.1
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as QDEL's earnings are expected to grow with 33.27% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y34.34%
EPS Next 3Y33.27%

0

5. Dividend

5.1 Amount

QDEL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

QUIDELORTHO CORP

NASDAQ:QDEL (4/22/2025, 8:00:00 PM)

After market: 24.75 +0.29 (+1.19%)

24.46

-0.1 (-0.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners109.74%
Inst Owner Change0.56%
Ins Owners0.49%
Ins Owner Change0.41%
Market Cap1.65B
Analysts76
Price Target54.5 (122.81%)
Short Float %6.42%
Short Ratio4.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.37%
Min EPS beat(2)4.59%
Max EPS beat(2)162.15%
EPS beat(4)4
Avg EPS beat(4)61.93%
Min EPS beat(4)4.59%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)32.62%
EPS beat(12)9
Avg EPS beat(12)35.38%
EPS beat(16)11
Avg EPS beat(16)28.34%
Revenue beat(2)1
Avg Revenue beat(2)5.13%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)11.02%
Revenue beat(4)3
Avg Revenue beat(4)3.15%
Min Revenue beat(4)-0.75%
Max Revenue beat(4)11.02%
Revenue beat(8)6
Avg Revenue beat(8)1.91%
Revenue beat(12)9
Avg Revenue beat(12)2.77%
Revenue beat(16)11
Avg Revenue beat(16)4.19%
PT rev (1m)0%
PT rev (3m)0.54%
EPS NQ rev (1m)-5.8%
EPS NQ rev (3m)-9.85%
EPS NY rev (1m)-1.57%
EPS NY rev (3m)-4.78%
Revenue NQ rev (1m)-1.09%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)-3.19%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE 13.22
Fwd PE 10.18
P/S 0.59
P/FCF N/A
P/OCF 19.88
P/B 0.55
P/tB N/A
EV/EBITDA 8.1
EPS(TTM)1.85
EY7.56%
EPS(NY)2.4
Fwd EY9.83%
FCF(TTM)-1.66
FCFYN/A
OCF(TTM)1.23
OCFY5.03%
SpS41.26
BVpS44.25
TBVpS-5.94
PEG (NY)0.44
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.94%
ROE -68.76%
ROCE 0.84%
ROIC 0.67%
ROICexc 0.68%
ROICexgc 1.86%
OM 1.65%
PM (TTM) N/A
GM 46.23%
FCFM N/A
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score3
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA 4.29
Cap/Depr 43.03%
Cap/Sales 7.01%
Interest Coverage 0.26
Cash Conversion 16.63%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.69
Altman-Z 0.82
F-Score3
WACC9.35%
ROIC/WACC0.07
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.21%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-46.15%
EPS Next Y29.93%
EPS Next 2Y34.34%
EPS Next 3Y33.27%
EPS Next 5Y28.34%
Revenue 1Y (TTM)-7.17%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-4.69%
Revenue Next Year-2.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.2%
Revenue Next 5Y2.57%
EBIT growth 1Y-81.86%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year935.81%
EBIT Next 3Y135.12%
EBIT Next 5Y92.11%
FCF growth 1Y-258.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.38%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%